SAB Biotherapeutics, Inc. Warrant (SABSW) is a publicly traded BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector company. As of October 22, 2026, SABSW trades at $0.00 with a market cap of $0 and a P/E ratio of 0.00. SABSW moved -97.67% today. Year to date, SABSW is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SABSW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SAB Biotherapeutics, Inc. Warrant (SABSW) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SABSW moved -97.67% today.
| Metric | Value |
|---|---|
| Price | $0.00 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 581.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
SABSW analyst coverage data. Average price target: $0.00.